Aileron Therapeutics Announces Nonclinical Myelopreservation Results For ALRN-6924 At 2019 AACR-NCI-EORTC Conference; Results Showed It 'prevented the toxic side effects of chemotherapy in normal cells and enhanced the anti-cancer activity of chemotherapy

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!